Quince Therapeutics Inc. Com
13F holders, Q1 2026 (March 31)6holders
$0.10avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Quince Therapeutics Inc. Com in their 13F filings. The largest holders were Gen-Wealth Partners Inc ($3K), Catalyst Funds Management Pty Ltd ($3K) and Fortitude Family Office, LLC ($821).
- Company
- Quince Therapeutics Inc. Com
- CUSIP
- 22053A206
- Latest filing quarter
- Q1 2026
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $8K |
| Exits | 0 | $0 |
Ownership 6 holders
| Gen-Wealth Partners Inc | 0.00% | New | 33,018 | $3K |
| Catalyst Funds Management Pty Ltd | 0.00% | New | 30,000 | $3K |
| Fortitude Family Office, LLC | 0.00% | New | 8,095 | $821 |
| Advisory Services Network, LLC | 0.00% | New | 5,500 | $558 |
| Parallel Advisors, LLC | 0.00% | New | 795 | $81 |
| SBI Securities Co., Ltd. | 0.00% | New | 135 | $14 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC COM's weight in each manager's 13F, not the share of Quince Therapeutics Inc. Com the manager owns.